BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2007
View Archived Issues
New compounds for respiratory disorders claimed in recent patent literature
Read More
Monarsen improves myasthenia gravis status
Read More
Cognitive function not worsened in children with behavior disorders given risperidone
Read More
YM-150 effective and safe as venous thromboembolism prophylaxis
Read More
Axcan Pharma announces third quarter 2007 results
Read More
New antiinfective compounds described in recent patent literature
Read More
Antigenics reports second quarter 2007 results
Read More
PTC Therapeutics patents disclose novel compounds for HCV infections
Read More
Positive results for Antisoma's ASA-404 in phase II lung cancer trial
Read More
Newron and Merck report preliminary results of safinamide phase III trial for PD
Read More
Alpharma and Institut Biochimique sign NSAID patch marketing agreement
Read More
FDA grants orphan drug designation to Pharmion and MethylGene's MGCD-0103
Read More
Abraxis BioScience and TRSI enter epothilone licensing agreement for cancer
Read More
Genta begins phase III trial of Genasense for advanced melanoma
Read More
Interim data from phase II trial of HIV vaccine tgAAC-09 reported by Targeted Genetics
Read More
Daiichi Sankyo and Forest to copromote antihypertensive drug Azor
Read More
Eisai receives approval for additional efficacy and dosage for Aricept in Japan
Read More
SARMs designed at BMS with selectivity for muscle over prostate
Read More
Promising 11beta.-HSD1 inhibitor with potential in endocrine and metabolic disorders
Read More
Potential migraine therapeutics in development at Merck
Read More
Fast track designation for Marqibo in treatment of relapsed ALL
Read More
AstraZeneca profiles series of dual CXCR2/CCR2B antagonists for inflammation
Read More
